Panbela Therapeutics, Inc. Retained Earnings
Panbela Therapeutics, Inc. had Retained Earnings of -$146.94 million as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2024-11-14
- 2024-09-30: Retained Earnings (Accumulated Deficit) -$146.94M.
- 2024-06-30: Retained Earnings (Accumulated Deficit) -$139.76M.
- 2024-03-31: Retained Earnings (Accumulated Deficit) -$132.62M.
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$125.50M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2024-09-30 | -$146.94M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$139.76M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | -$132.62M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | -$125.50M 10-Q · filed 2024-11-14 | |
| 2023-09-30 | -$139.80M 10-Q · filed 2024-08-13 | -$109.88M 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$102.05M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | -$96.21M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | -$91.09M 10-K · filed 2024-03-26 | |
| 2022-09-30 | -$86.36M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$81.96M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | -$59.83M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | -$56.16M 10-K · filed 2023-03-16 | |
| 2021-09-30 | -$52.62M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | -$50.47M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | -$48.28M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | -$46.03M 10-K · filed 2022-03-24 | |
| 2020-09-30 | -$45.15M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | -$43.48M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | -$43.06M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | -$41.26M 10-K · filed 2021-03-25 | |
| 2019-09-30 | -$40.28M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | -$38.91M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | -$36.64M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | -$35.06M 10-K · filed 2020-03-24 | |
| 2018-09-30 | -$34.32M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | -$33.39M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | -$30.91M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | -$29.15M 10-K · filed 2019-03-22 | |
| 2017-09-30 | -$26.99M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | -$25.77M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | -$24.35M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | -$18.78M 10-K · filed 2018-03-21 | |
| 2016-09-30 | -$16.54M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | -$15.47M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | -$14.49M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | -$13.67M 10-K · filed 2017-03-30 | |
| 2015-09-30 | -$12.94M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | -$14.17M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | -$14.08M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | -$8.57M 10-K · filed 2016-03-08 | -$13.99M 10-K · filed 2015-03-30 |
| 2014-09-30 | -$14.15M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | -$14.05M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | -$13.99M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | -$13.88M 10-K · filed 2015-03-30 | |
| 2013-09-30 | -$13.86M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | -$13.80M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$13.75M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | -$13.67M 10-K · filed 2014-03-28 | |
| 2011-12-31 | -$13.92M 10-K · filed 2013-03-26 |